Fischer Medical Ventures Receives Upgraded Stock Call from MarketsMOJO

Fischer Medical Ventures, a smallcap company in the chemicals industry, has recently received an upgraded stock call from MarketsMOJO. The stock has been upgraded to a 'Hold' rating on September 16, 2024.
The upgrade is based on positive results in June 2024, with the company's PAT(Q) reaching its highest at Rs 0.84 crore. The stock is currently in a bullish range and has shown a 1.16% return since September 12, 2024. Multiple technical factors such as MACD, Bollinger Band, KST, and OBV are also indicating a bullish trend for the stock.

In terms of market performance, Fischer Medical Ventures has outperformed the market (BSE 500) with a return of 753.26% in the last year, compared to the market's 34.97% return.

However, the company's long-term fundamental strength is weak due to operating losses and poor growth in net sales and operating profit over the last 5 years. Additionally, the company has a high debt-to-equity ratio of 0 times.

The stock is also trading at a very expensive valuation with a price-to-book value of 45.9, compared to its historical average. Despite its strong market performance, the company's profits have fallen by 0% in the past year.

It is worth noting that despite its smallcap size, domestic mutual funds hold only 0% of the company. This could indicate that they are either not comfortable with the current price or have not conducted in-depth research on the company.